Radhakrishnan Karthik 4
4 · Opexa Therapeutics, Inc. · Filed Apr 1, 2013
Insider Transaction Report
Form 4
Radhakrishnan Karthik
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2013-03-29+125,000→ 125,000 totalExercise: $2.34Exp: 2023-03-29→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]Quarterly vesting commencing on the date of grant over three years.